Scientific Reports (Dec 2021)

Angicin, a novel bacteriocin of Streptococcus anginosus

  • Verena Vogel,
  • Richard Bauer,
  • Stefanie Mauerer,
  • Nicole Schiffelholz,
  • Christian Haupt,
  • Gerd M. Seibold,
  • Marcus Fändrich,
  • Paul Walther,
  • Barbara Spellerberg

DOI
https://doi.org/10.1038/s41598-021-03797-5
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 16

Abstract

Read online

Abstract As a conserved defense mechanism, many bacteria produce antimicrobial peptides, called bacteriocins, which provide a colonization advantage in a multispecies environment. Here the first bacteriocin of Streptococcus anginosus, designated Angicin, is described. S. anginosus is commonly described as a commensal, however it also possesses a high pathogenic potential. Therefore, understanding factors contributing to its host colonization and persistence are important. A radial diffusion assay was used to identify S. anginosus BSU 1211 as a potent bacteriocin producer. By genetic mutagenesis the background of bacteriocin production and the bacteriocin gene itself were identified. Synthetic Angicin shows high activity against closely related streptococci, listeria and vancomycin resistant enterococci. It has a fast mechanism of action and causes a membrane disruption in target cells. Angicin, present in cell free supernatant, is insensitive to changes in temperature from − 70 to 90 °C and pH values from 2 to 10, suggesting that it represents an interesting compound for potential applications in food preservation or clinical settings.